Keywords: Ben Venue Labs. Boehringer Ingelheim, EMA, GMP shortcomings, USA, EMA

EMA makes interim recommendations to deal with shortcomings at Ben Venue Labs

Article | 23 November 2011

The European Medicines Agency (EMA) is currently reviewing shortcomings in quality assurance identified during a Good Manufacturing Practice (GMP) inspection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing